Ravgen

Columbia, United States Founded: 2000 • Age: 26 yrs
Fetal DNA in maternal blood is analyzed for prenatal diagnostics.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 11 Brand Intelligence

About Ravgen

Ravgen is a company based in Columbia (United States) founded in 2000. Ravgen offers products and services including Prenatal Down Syndrome Test, Single Gene Disorder Test, and Non-Invasive Prenatal Paternity Test. Ravgen operates in a competitive market with competitors including Natera, GreenLight Biosciences, Color, BillionToOne and Veritas Genetics, among others.

  • Headquarter Columbia, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ravgen, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $2.48 M (USD), Debt – Conventional

    Oct 27, 2021

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ravgen

Ravgen offers a comprehensive portfolio of products and services, including Prenatal Down Syndrome Test, Single Gene Disorder Test, and Non-Invasive Prenatal Paternity Test.

Product name locked
Category locked
Primary

Detects extra chromosome 21 in fetal DNA from maternal blood.

Product name locked
Category locked
Locked

Identifies disorders like CF and SMA using non-invasive methods.

Product name locked
Category locked
Locked

Determines paternity with fetal DNA from maternal blood sample.

People of Ravgen

Headcount 1-10
Employee Profiles 1
Board Members and Advisors 12
Employee Profiles
People
Ravinder Dhallan
Chairman & CEO

Unlock access to complete

Board Members and Advisors
people
Mark D. Adams
Advisor
people
Russell Lewis
Advisor
people
Edward K. Mottern
Director
people
Daniel I. Weber
Advisor

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Ravgen

Investments & Acquisitions by Ravgen

Investments
Premium access

Investment portfolio details for Ravgen

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ravgen

Premium access

Detailed financials for Ravgen

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ravgen Comparisons

Ravgen Primary company
Description
Fetal DNA in maternal blood is analyzed for prenatal diagnos...
Location
Columbia, United States
Founded Year
2000
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ravgen

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ravgen

Ravgen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, GreenLight Biosciences, Color, BillionToOne and Veritas Genetics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of cell-free DNA testing for oncology, women’s health, and organ health
Locked Locked Locked
RNA-based platform for life sciences is developed by GreenLight Biosciences.
Locked Locked Locked
Cancer care is delivered through a virtual clinic by Color.
Locked Locked Locked
Provider of cell-free cancer liquid biopsy test
Locked Locked Locked
Genetic testing products for health risks and traits are offered.
Locked Locked Locked
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
Premium access

Detailed competitors of Ravgen

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ravgen

Premium access

Complete news archive for Ravgen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravgen

Ravgen was founded in 2000 and raised its 1st funding round 21 years after it was founded.

Ravgen is headquartered in Columbia, United States.

Ravgen was founded in 2000 and is headquartered in Columbia, United States. Operations focus on the biotechnology sector, where non-invasive prenatal diagnostic tests are developed through analysis of fetal DNA in maternal blood. Services include detection of single gene disorders such as cystic fibrosis, sickle cell anemia, and Down syndrome, as well as paternity establishment during the first trimester.

Ravgen's top competitors include GreenLight Biosciences, Natera and BillionToOne.

Ravgen offers Prenatal Down Syndrome Test, Single Gene Disorder Test, and Non-Invasive Prenatal Paternity Test.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available